These data suggest that obesity may alter the dynamics of residual tumor cells by increasing the number of cells that survive and persist following treatment of the primary tumor (i.e., HER2 inhibition), such that the pool of residual tumor cells “at risk” for reentry into the cell cycle is increased and, by extension, the risk of recurrence is increased. This evidence concerns the gene ERBB2 and neoplasm.